JDQ-443

JDQ-443 · Janssen Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JDQ-443, covering 2024-05-29 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation [Phase 1, Phase 2]